Syringes and Needles Market Size, Share and Growth Outlook 2026: By Product Category (Syringes, Needles), By Material, By Application, By End User, Companies to 2034.
The global Syringes and Needles Market size is forecast to increase from $27.48 Billion in 2026 to $48.5 Billion in 2034 at a CAGR of 7.36% between 2026 and 2034.
The Syringes and Needles market report provides detailed analysis and outlook of Syringes and Needles segments including By Product Category (Syringes, Needles ), By Material (Plastic, Glass, Stainless Steel), By Application (Insulin Administration, Vaccination/Immunization, Blood Collection, General Surgery, Ophthalmic Procedures, Dental, Others ), By End User (Hospitals and Clinics, Ambulatory Surgery Centers (ASCs), Diagnostic Laboratories, Home Healthcare Settings, Others) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Syringes and Needles Industry Overview
Advanced Drug Delivery, Safety Engineering, and Home Healthcare Are Transforming the Syringes and Needles Market
The global syringes and needles industry is undergoing substantial transformation as healthcare systems increasingly prioritize patient safety, advanced drug delivery technologies, biologic therapies, and decentralized care models. Syringes and needles remain foundational medical devices across hospitals, ambulatory care centers, vaccination programs, diagnostic procedures, and chronic disease management. However, the rapid expansion of biologics, cell and gene therapies, and home-based treatment models is reshaping demand patterns toward specialized delivery systems, smart injectables, and safety-engineered vascular access technologies. Manufacturers are increasingly investing in connected devices, wearable delivery systems, prefilled syringes, and automated administration platforms designed to improve treatment adherence, reduce clinical burden, and support precision medicine applications.
Transition from Hospital-Based Infusion to Advanced Subcutaneous Delivery Drives Innovation
The pharmaceutical industry's ongoing shift from intravenous to subcutaneous drug administration is creating significant opportunities for innovation across syringe and needle technologies. Drug developers increasingly seek delivery systems capable of supporting high-volume biologics while improving patient convenience and expanding home-based treatment options. Reflecting this trend, BD continues to expand its advanced drug delivery portfolio through technologies such as the BD Libertas™ wearable injector, designed to facilitate subcutaneous administration of high-dose biologic therapies outside traditional clinical settings. The company's introduction of the BD iDFill™ RFID-based identification solution for prefillable syringes further highlights the growing emphasis on traceability, digital connectivity, and pharmaceutical manufacturing efficiency. These developments demonstrate the broader transition toward intelligent and patient-centric drug delivery ecosystems.
Safety, Automation, and Precision Fluid Management Strengthen Clinical Infrastructure
The increasing complexity of healthcare delivery is driving demand for technologies that improve procedural safety, workflow efficiency, and therapeutic precision. Advanced vascular access systems and automated fluid management platforms are becoming increasingly important across acute care, specialty therapeutics, and regenerative medicine applications. Supporting this trend, BD introduced the CentroVena One™ insertion system to simplify central venous access procedures while enhancing procedural efficiency and patient safety. Meanwhile, Terumo Blood and Cell Technologies continues to expand the application of its automated processing platforms through collaborations focused on advanced cellular therapies, including the transition of regulatory T-cell manufacturing onto the Quantum Flex platform. Although developed for cell therapy production, these technologies reflect broader industry investments in precision fluid management, automation, and scalable therapeutic delivery infrastructure. These developments collectively underscore the evolution of the syringes and needles industry toward highly specialized, connected, and technologically advanced delivery systems.
Syringes and Needles Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Syringes and Needles market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical (ICU Medical, Inc.), Cardinal Health, Inc., Nipro Corporation, Gerresheimer AG, Retractable Technologies, Inc., Schott AG, Hindustan Syringes & Medical Devices Ltd. (HMD). The Syringes and Needles market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Syringes and Needles industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Syringes and Needles industry include- Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical (ICU Medical, Inc.), Cardinal Health, Inc., Nipro Corporation, Gerresheimer AG, Retractable Technologies, Inc., Schott AG, Hindustan Syringes & Medical Devices Ltd. (HMD). The Syringes and Needles market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Syringes and Needles Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Syringes and Needles market remains one of the strongest-performing segments in the country.
The US Syringes and Needles Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Syringes and Needles market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Syringes and Needles industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Syringes and Needles markets
Canada's strong Syringes and Needles sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Syringes and Needles market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Syringes and Needles Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Syringes and Needles market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Syringes and Needles population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Syringes and Needles industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Syringes and Needles market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Syringes and Needles sales through 2034
France Syringes and Needles companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Syringes and Needles Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Syringes and Needles distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Syringes and Needles Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Syringes and Needles market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Syringes and Needles industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Syringes and Needles industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Syringes and Needles Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Syringes and Needles market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Syringes and Needles market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Syringes and Needles Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Syringes and Needles Market Segmentation
By Product Category
Syringes
Needles
By Material
Plastic
Glass
Stainless Steel
By Application
Insulin Administration
Vaccination/Immunization
Blood Collection
General Surgery
Ophthalmic Procedures
Dental
Others
By End User
Hospitals and Clinics
Ambulatory Surgery Centers (ASCs)
Diagnostic Laboratories
Home Healthcare Settings
Others
Leading Companies in Syringes and Needles Industry (2026)
Becton, Dickinson and Company
B. Braun Melsungen AG
Terumo Corporation
Smiths Medical (ICU Medical, Inc.)
Cardinal Health, Inc.
Nipro Corporation
Gerresheimer AG
Retractable Technologies, Inc.
Schott AG
Hindustan Syringes & Medical Devices Ltd. (HMD)
Countries Included
The Syringes and Needles market report provides detailed analysis and outlook of Syringes and Needles segments including By Product Category (Syringes, Needles ), By Material (Plastic, Glass, Stainless Steel), By Application (Insulin Administration, Vaccination/Immunization, Blood Collection, General Surgery, Ophthalmic Procedures, Dental, Others ), By End User (Hospitals and Clinics, Ambulatory Surgery Centers (ASCs), Diagnostic Laboratories, Home Healthcare Settings, Others) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Syringes and Needles Industry Overview
Advanced Drug Delivery, Safety Engineering, and Home Healthcare Are Transforming the Syringes and Needles Market
The global syringes and needles industry is undergoing substantial transformation as healthcare systems increasingly prioritize patient safety, advanced drug delivery technologies, biologic therapies, and decentralized care models. Syringes and needles remain foundational medical devices across hospitals, ambulatory care centers, vaccination programs, diagnostic procedures, and chronic disease management. However, the rapid expansion of biologics, cell and gene therapies, and home-based treatment models is reshaping demand patterns toward specialized delivery systems, smart injectables, and safety-engineered vascular access technologies. Manufacturers are increasingly investing in connected devices, wearable delivery systems, prefilled syringes, and automated administration platforms designed to improve treatment adherence, reduce clinical burden, and support precision medicine applications.
Transition from Hospital-Based Infusion to Advanced Subcutaneous Delivery Drives Innovation
The pharmaceutical industry's ongoing shift from intravenous to subcutaneous drug administration is creating significant opportunities for innovation across syringe and needle technologies. Drug developers increasingly seek delivery systems capable of supporting high-volume biologics while improving patient convenience and expanding home-based treatment options. Reflecting this trend, BD continues to expand its advanced drug delivery portfolio through technologies such as the BD Libertas™ wearable injector, designed to facilitate subcutaneous administration of high-dose biologic therapies outside traditional clinical settings. The company's introduction of the BD iDFill™ RFID-based identification solution for prefillable syringes further highlights the growing emphasis on traceability, digital connectivity, and pharmaceutical manufacturing efficiency. These developments demonstrate the broader transition toward intelligent and patient-centric drug delivery ecosystems.
Safety, Automation, and Precision Fluid Management Strengthen Clinical Infrastructure
The increasing complexity of healthcare delivery is driving demand for technologies that improve procedural safety, workflow efficiency, and therapeutic precision. Advanced vascular access systems and automated fluid management platforms are becoming increasingly important across acute care, specialty therapeutics, and regenerative medicine applications. Supporting this trend, BD introduced the CentroVena One™ insertion system to simplify central venous access procedures while enhancing procedural efficiency and patient safety. Meanwhile, Terumo Blood and Cell Technologies continues to expand the application of its automated processing platforms through collaborations focused on advanced cellular therapies, including the transition of regulatory T-cell manufacturing onto the Quantum Flex platform. Although developed for cell therapy production, these technologies reflect broader industry investments in precision fluid management, automation, and scalable therapeutic delivery infrastructure. These developments collectively underscore the evolution of the syringes and needles industry toward highly specialized, connected, and technologically advanced delivery systems.
Syringes and Needles Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Syringes and Needles market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical (ICU Medical, Inc.), Cardinal Health, Inc., Nipro Corporation, Gerresheimer AG, Retractable Technologies, Inc., Schott AG, Hindustan Syringes & Medical Devices Ltd. (HMD). The Syringes and Needles market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Syringes and Needles industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Syringes and Needles Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Syringes and Needles companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Syringes and Needles markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Syringes and Needles industry include- Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical (ICU Medical, Inc.), Cardinal Health, Inc., Nipro Corporation, Gerresheimer AG, Retractable Technologies, Inc., Schott AG, Hindustan Syringes & Medical Devices Ltd. (HMD). The Syringes and Needles market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Syringes and Needles Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Syringes and Needles market remains one of the strongest-performing segments in the country.
The US Syringes and Needles Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Syringes and Needles market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Syringes and Needles industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Syringes and Needles markets
Canada's strong Syringes and Needles sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Syringes and Needles market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Syringes and Needles Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Syringes and Needles market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Syringes and Needles population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Syringes and Needles industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Syringes and Needles market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Syringes and Needles sales through 2034
France Syringes and Needles companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Syringes and Needles Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Syringes and Needles distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Syringes and Needles Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Syringes and Needles market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Syringes and Needles industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Syringes and Needles industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Syringes and Needles Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Syringes and Needles market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Syringes and Needles market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Syringes and Needles Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Syringes and Needles Market Segmentation
By Product Category
Syringes
Needles
By Material
Plastic
Glass
Stainless Steel
By Application
Insulin Administration
Vaccination/Immunization
Blood Collection
General Surgery
Ophthalmic Procedures
Dental
Others
By End User
Hospitals and Clinics
Ambulatory Surgery Centers (ASCs)
Diagnostic Laboratories
Home Healthcare Settings
Others
Leading Companies in Syringes and Needles Industry (2026)
Becton, Dickinson and Company
B. Braun Melsungen AG
Terumo Corporation
Smiths Medical (ICU Medical, Inc.)
Cardinal Health, Inc.
Nipro Corporation
Gerresheimer AG
Retractable Technologies, Inc.
Schott AG
Hindustan Syringes & Medical Devices Ltd. (HMD)
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Syringes and Needles Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Syringes and Needles Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SYRINGES AND NEEDLES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Syringes and Needles Markets in 2026
3.2. Global Historic and Forecast Syringes and Needles Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Syringes and Needles Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Syringes and Needles Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Syringes and Needles Value Chain
CHAPTER 4- SYRINGES AND NEEDLES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Syringes and Needles Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SYRINGES AND NEEDLES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Category
Syringes
Needles
By Material
Plastic
Glass
Stainless Steel
By Application
Insulin Administration
Vaccination/Immunization
Blood Collection
General Surgery
Ophthalmic Procedures
Dental
Others
By End User
Hospitals and Clinics
Ambulatory Surgery Centers (ASCs)
Diagnostic Laboratories
Home Healthcare Settings
Others
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Syringes and Needles Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Syringes and Needles Market Trends and Growth Opportunities to 2034
7.5. North America Syringes and Needles Market Size Outlook by Type
7.6. North America Syringes and Needles Market Size Outlook by Application
7.7. North America Syringes and Needles Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Syringes and Needles Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Syringes and Needles Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Syringes and Needles Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Syringes and Needles Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Syringes and Needles Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Syringes and Needles Companies
CHAPTER 8- EUROPE SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Syringes and Needles Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Syringes and Needles Market Trends and Growth Opportunities to 2034
8.5. Europe Syringes and Needles Market Size Outlook by Type
8.6. Europe Syringes and Needles Market Size Outlook by Application
8.7. Europe Syringes and Needles Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Syringes and Needles Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Syringes and Needles Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Syringes and Needles Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Syringes and Needles Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Syringes and Needles Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Syringes and Needles Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Syringes and Needles Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Syringes and Needles Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Syringes and Needles Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Syringes and Needles Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Syringes and Needles Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Syringes and Needles Companies
CHAPTER 9- ASIA PACIFIC SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Syringes and Needles Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Syringes and Needles Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Syringes and Needles Market Size Outlook by Type
9.6. Asia Pacific Syringes and Needles Market Size Outlook by Application
9.7. Asia Pacific Syringes and Needles Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Syringes and Needles Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Syringes and Needles Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Syringes and Needles Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Syringes and Needles Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Syringes and Needles Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Syringes and Needles Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Syringes and Needles Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Syringes and Needles Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Syringes and Needles Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Syringes and Needles Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Syringes and Needles Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Syringes and Needles Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Syringes and Needles Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Syringes and Needles Market Trends and Growth Opportunities to 2034
10.5. South and Central America Syringes and Needles Market Size Outlook by Type
10.6. South and Central America Syringes and Needles Market Size Outlook by Application
10.7. South and Central America Syringes and Needles Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Syringes and Needles Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Syringes and Needles Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Syringes and Needles Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Syringes and Needles Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Syringes and Needles Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Syringes and Needles Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Syringes and Needles Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Syringes and Needles Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Syringes and Needles Market Size Outlook by Type
11.6. Middle East and Africa Syringes and Needles Market Size Outlook by Application
11.7. Middle East and Africa Syringes and Needles Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Syringes and Needles Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Syringes and Needles Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Syringes and Needles Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Syringes and Needles Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Syringes and Needles Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Syringes and Needles Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Syringes and Needles Industry
Becton, Dickinson and Company
B. Braun Melsungen AG
Terumo Corporation
Smiths Medical (ICU Medical, Inc.)
Cardinal Health, Inc.
Nipro Corporation
Gerresheimer AG
Retractable Technologies, Inc.
Schott AG
Hindustan Syringes & Medical Devices Ltd. (HMD)
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Syringes and Needles Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Syringes and Needles Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SYRINGES AND NEEDLES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Syringes and Needles Markets in 2026
3.2. Global Historic and Forecast Syringes and Needles Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Syringes and Needles Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Syringes and Needles Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Syringes and Needles Value Chain
CHAPTER 4- SYRINGES AND NEEDLES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Syringes and Needles Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SYRINGES AND NEEDLES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Category
Syringes
Needles
By Material
Plastic
Glass
Stainless Steel
By Application
Insulin Administration
Vaccination/Immunization
Blood Collection
General Surgery
Ophthalmic Procedures
Dental
Others
By End User
Hospitals and Clinics
Ambulatory Surgery Centers (ASCs)
Diagnostic Laboratories
Home Healthcare Settings
Others
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Syringes and Needles Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Syringes and Needles Market Trends and Growth Opportunities to 2034
7.5. North America Syringes and Needles Market Size Outlook by Type
7.6. North America Syringes and Needles Market Size Outlook by Application
7.7. North America Syringes and Needles Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Syringes and Needles Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Syringes and Needles Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Syringes and Needles Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Syringes and Needles Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Syringes and Needles Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Syringes and Needles Companies
CHAPTER 8- EUROPE SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Syringes and Needles Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Syringes and Needles Market Trends and Growth Opportunities to 2034
8.5. Europe Syringes and Needles Market Size Outlook by Type
8.6. Europe Syringes and Needles Market Size Outlook by Application
8.7. Europe Syringes and Needles Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Syringes and Needles Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Syringes and Needles Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Syringes and Needles Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Syringes and Needles Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Syringes and Needles Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Syringes and Needles Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Syringes and Needles Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Syringes and Needles Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Syringes and Needles Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Syringes and Needles Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Syringes and Needles Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Syringes and Needles Companies
CHAPTER 9- ASIA PACIFIC SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Syringes and Needles Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Syringes and Needles Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Syringes and Needles Market Size Outlook by Type
9.6. Asia Pacific Syringes and Needles Market Size Outlook by Application
9.7. Asia Pacific Syringes and Needles Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Syringes and Needles Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Syringes and Needles Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Syringes and Needles Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Syringes and Needles Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Syringes and Needles Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Syringes and Needles Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Syringes and Needles Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Syringes and Needles Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Syringes and Needles Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Syringes and Needles Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Syringes and Needles Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Syringes and Needles Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Syringes and Needles Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Syringes and Needles Market Trends and Growth Opportunities to 2034
10.5. South and Central America Syringes and Needles Market Size Outlook by Type
10.6. South and Central America Syringes and Needles Market Size Outlook by Application
10.7. South and Central America Syringes and Needles Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Syringes and Needles Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Syringes and Needles Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Syringes and Needles Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Syringes and Needles Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Syringes and Needles Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Syringes and Needles Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SYRINGES AND NEEDLES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Syringes and Needles Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Syringes and Needles Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Syringes and Needles Market Size Outlook by Type
11.6. Middle East and Africa Syringes and Needles Market Size Outlook by Application
11.7. Middle East and Africa Syringes and Needles Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Syringes and Needles Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Syringes and Needles Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Syringes and Needles Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Syringes and Needles Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Syringes and Needles Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Syringes and Needles Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Syringes and Needles Industry
Becton, Dickinson and Company
B. Braun Melsungen AG
Terumo Corporation
Smiths Medical (ICU Medical, Inc.)
Cardinal Health, Inc.
Nipro Corporation
Gerresheimer AG
Retractable Technologies, Inc.
Schott AG
Hindustan Syringes & Medical Devices Ltd. (HMD)
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
